KOUNTOUPES DENHAM CARR & REID, LLC for TEVA PHARMACEUTICALS USA, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 20, 2018 | $20,000 | Replaced |
| 1st Quarter - Termination (this page) | Apr 20, 2018 | $20,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Proposals related to affordability and pricing of pharmaceuticals including issues related to H. R. 2212 and S. 974, CREATES Act of 2017; H. R. 2051 - FAST Generics Act.
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE HERSHEY CARR | — |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Medicare/Medicaid MMM
Provisions affecting the Medicaid rebate program included in the Bipartisan Budget Act of 2015.
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in the issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE HERSHEY CARR | — |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Pharmacy PHA
Proposals related to affordability and pricing of pharmaceuticals including H. R. 2212 and S.974 Creating & Restoring Equal Access to Equivalent Samples Act ("CREATES Act") for 2017; H. R. 2051 - FAST Generics Act.
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA Inc., has an interest in this issues listed.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE HERSHEY CARR | — |
| LISA KOUNTOUPES | — |
| DAVID PAUL PELUSO | — |
| ROSE SULLIVAN (LISTED IN ERROR) | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.